UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000006058 |
|---|---|
| Receipt number | R000007168 |
| Scientific Title | Phase II trial of S-1 based therapy+/-Trastuzmab combination therapy for unresectable gastric cancer |
| Date of disclosure of the study information | 2011/07/28 |
| Last modified on | 2011/07/28 12:17:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Phase II trial of S-1 based therapy+/-Trastuzmab combination therapy for unresectable gastric cancer
Acronym
S-1 based therapy+/-Trastuzmab combination therapy
Scientific Title
Phase II trial of S-1 based therapy+/-Trastuzmab combination therapy for unresectable gastric cancer
Scientific Title:Acronym
S-1 based therapy+/-Trastuzmab combination therapy
Region
| Japan |
Condition
Condition
unresectable gastric cancer
Classification by specialty
| Gastroenterology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
We confirm response rate and adverse event of S-1 based therapy
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Phase II
Assessment
Primary outcomes
response rate
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
S-1 80mg/m2 day1-14
CDDP 60mg/m2 day1
Trastuzumab 6mg/kg day1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
All of people were eligible for inclusion if they had histologically comformed inoperable, recurrent, or metastatic adenocarcinoma. ECOG performance status 0-2: adequate organ function; and measurable disease
Key exclusion criteria
We exclude all patient who are not eligible for the inclusion
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuya Matsumoto |
Organization
Tottori University school of medicine
Division name
2nd department of internal medicine
Zip code
Address
36-1 Nishi-cho, Yonago-shi, Japan, 683-8504
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Tottori University school of medicine
Division name
2nd department of internal medicine
Zip code
Address
TEL
Homepage URL
ayano0620@hotmail.co.jp
Sponsor or person
Institute
2nd department of internal medicine Tottori University school of medicine
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2011 | Year | 07 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2011 | Year | 07 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 07 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2011 | Year | 07 | Month | 28 | Day |
Last modified on
| 2011 | Year | 07 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007168
